Cargando…

Retrospective Analysis on Antimicrobial Resistance Trends and Prevalence of β-lactamases in Escherichia coli and ESKAPE Pathogens Isolated from Arabian Patients during 2000–2020

The production of diverse and extended spectrum β-lactamases among Escherichia coli and ESKAPE pathogens is a growing threat to clinicians and public health. We aim to provide a comprehensive analysis of evolving trends of antimicrobial resistance and β-lactamases among E. coli and ESKAPE pathogens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nasser, Mahfouz, Palwe, Snehal, Bhargava, Ram Naresh, Feuilloley, Marc G. J., Kharat, Arun S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589750/ https://www.ncbi.nlm.nih.gov/pubmed/33096921 http://dx.doi.org/10.3390/microorganisms8101626

Ejemplares similares

In-Vitro Selection of Ceftazidime/Avibactam Resistance in OXA-48-Like-Expressing Klebsiella pneumoniae: In-Vitro and In-Vivo Fitness, Genetic Basis and Activities of β-Lactam Plus Novel β-Lactamase Inhibitor or β-Lactam Enhancer Combinations
por: Palwe, Snehal, et al.
Publicado: (2021)

ESKAPE Bacteria and Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolated from Wastewater and Process Water from German Poultry Slaughterhouses
por: Savin, Mykhailo, et al.
Publicado: (2020)

Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens
por: Vrancianu, Corneliu Ovidiu, et al.
Publicado: (2020)

Silver Nanoforms as a Therapeutic Agent for Killing Escherichia coli and Certain ESKAPE Pathogens
por: Kedziora, A., et al.
Publicado: (2016)

Antimicrobial resistance profiles of ESKAPE and Escherichia coli isolated from blood at a tertiary hospital in China
por: Wei, Dan-Dan, et al.
Publicado: (2020)

Protective effect of SARS‐CoV‐2 preventive measures against ESKAPE and Escherichia coli infections
por: Gaspari, Rita, et al.
Publicado: (2021)

Eskape Infection Control: Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections (Adv. Sci. 1/2020)
por: Ma, Yu‐Xuan, et al.
Publicado: (2020)

Escherichia coli β-Lactamases: What Really Matters
por: Bajaj, Priyanka, et al.
Publicado: (2016)

Co-existence of beta-lactamases in clinical isolates of Escherichia coli from Kathmandu, Nepal
por: Pokhrel, Ram Hari, et al.
Publicado: (2014)

Extended Spectrum Beta-Lactamase Escherichia coli in River Waters Collected from Two Cities in Ghana, 2018–2020
por: Banu, Regina Ama, et al.
Publicado: (2021)

Transcriptome analysis of beta-lactamase genes in diarrheagenic Escherichia coli
por: Singh, Taru, et al.
Publicado: (2019)

Prevalence of Toxoplasma gondii infection in animals of the Arabian Peninsula between 2000–2020: A systematic review and meta‐analysis
por: Abdelgadier, Asmaa, et al.
Publicado: (2022)

Functional Differences between E. coli and ESKAPE Pathogen GroES/GroEL
por: Sivinski, Jared, et al.
Publicado: (2021)

The Epidemiology and Outcome of Biliary Atresia: Saudi Arabian National Study (2000–2018)
por: Al-Hussaini, Abdulrahman, et al.
Publicado: (2022)

Genetic Background of Escherichia coli and Extended-spectrum β-Lactamase Type
por: Branger, Catherine, et al.
Publicado: (2005)

Detection of plasmid-mediated AmpC β-lactamase in Escherichia coli
por: LIU, XIANGQUN, et al.
Publicado: (2016)

Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens
por: Santajit, Sirijan, et al.
Publicado: (2016)

Investigating the OXA Variants of ESKAPE Pathogens
por: Pandey, Deeksha, et al.
Publicado: (2021)

Editorial: ESKAPE biofilm: challenges and solutions
por: Tiwari, Vishvanath
Publicado: (2023)

Conditions Under Which Glutathione Disrupts the Biofilms and Improves Antibiotic Efficacy of Both ESKAPE and Non-ESKAPE Species
por: Das, Theerthankar, et al.
Publicado: (2019)

Meningitis Relapse in a Neonate: From Extended-Spectrum Beta-Lactamases-Producing Escherichia coli to Escherichia coli K1
por: Alkattan, Salma S, et al.
Publicado: (2022)

Extended-Spectrum β-Lactamase–producing Escherichia coli in Neonatal Care Unit
por: Johnson, James R.
Publicado: (2011)

Escherichia coli Producing CTX-M-2 β-Lactamase in Cattle, Japan
por: Shiraki, Yutaka, et al.
Publicado: (2004)

Extended Spectrum β-Lactamase–producing Escherichia coli in Neonatal Care Unit
por: Tschudin-Sutter, Sarah, et al.
Publicado: (2010)

New Delhi Metallo-β-Lactamase in Klebsiella pneumoniae and Escherichia coli, Canada
por: Mulvey, Michael R., et al.
Publicado: (2011)

New Delhi Metallo-β-Lactamase 4–producing Escherichia coli in Cameroon
por: Dortet, Laurent, et al.
Publicado: (2012)

CTX-M β-Lactamase Production and Virulence of Escherichia coli K1
por: Dubois, Damien, et al.
Publicado: (2009)

Molecular characterization of multiresistant Escherichia coli producing or not extended-spectrum β-lactamases
por: Ruiz del Castillo, Belén, et al.
Publicado: (2013)

Emergence of Escherichia coli producing OXA-48 β-lactamase in the community in Switzerland
por: Zurfluh, Katrin, et al.
Publicado: (2015)

The prevalence of Escherichia coli strains with extended spectrum beta-lactamases isolated in China
por: Liu, Haihong, et al.
Publicado: (2015)

Extended spectrum beta lactamase producing Escherichia coli tricuspid valve endocarditis
por: Waked, Rami, et al.
Publicado: (2020)

Antimicrobial Susceptibilities of Urinary Extended-spectrum β-lactamase Escherichia coli to Fosfomycin
por: Saeed, Nermin Kamal, et al.
Publicado: (2021)

Frequency of Beta-Lactamase Antibiotic Resistance Genes in Escherichia Coli and Klebsiella pneumoniae
por: Golsha, Roghieh, et al.
Publicado: (2021)

Structural Investigations of the Inhibition of Escherichia coli AmpC β-Lactamase by Diazabicyclooctanes
por: Lang, Pauline A., et al.
Publicado: (2021)

Exposure assessment of extended-spectrum beta-lactamases/AmpC beta-lactamases-producing Escherichia coli in meat in Denmark
por: Carmo, Luís P., et al.
Publicado: (2014)

Trend in Antibiotic Resistance of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli and Klebsiella Pneumoniae Bloodstream Infections
por: Bayraktar, Banu, et al.
Publicado: (2019)

Epidemiology of Shiga toxin producing Escherichia coli in Australia, 2000-2010
por: Vally, Hassan, et al.
Publicado: (2012)

Antimicrobial Activity of Gallium Compounds on ESKAPE Pathogens
por: Hijazi, Sarah, et al.
Publicado: (2018)

Are Antimicrobial Peptide Dendrimers an Escape from ESKAPE?
por: Kawano, Yayoi, et al.
Publicado: (2020)

CTX-M–Type β-Lactamases Affect Community Escherichia coli Treatment, Greece
por: Pournaras, Spyros, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_cnv44v5t3ep1ulfmu1qvlr8848